age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67.47998
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 2
| 11
| null | 0
| 7,020
| 5,177.6289
| null | 11.5
|
white
| 20.296875
| 23
| 0.761963
| 0.510986
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.25
|
no dnr
| 8
| 96
| 6.299805
| 80
| 20
| 37.59375
| null | 2.899902
| 0.5
| 1.5
| 139
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 266
| 1
|
77.758
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 9
| 17,610
| 10,376.9688
| null | 18.333328
|
white
| 36.398438
| 68
| 0.425964
| 0.306946
| 1
| 0
| 0
|
no
| 0.4
| 0
|
dnr after sadm
| 7
| 49
| 7.199219
| 94
| 36
| 34.19531
| 320
| 3.599609
| 1.599854
| 6.5
| 136
| 7.429688
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 15
| 1
|
36.27698
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 0
| 20,110
| 8,962.0156
| null | 28
|
white
| 23.5
| 29
| 0.888916
| 0.848999
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 11
| 54
| 18.296875
| 76
| 14
| 35.79688
| 195
| 2.799805
| 0.599976
| 0.799927
| 139
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,953
| 0
|
80.75
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 0
| 25,860
| 17,224.5469
| null | 14
|
white
| 20
| 29
| 0.747925
| 0.668945
| 2
| 1
| 0
|
yes
| 0.95
| 0.85
|
no dnr
| 23
| 100
| 11.398438
| 100
| 26
| 37.79688
| 322.5
| 2.899902
| 1.199951
| 1.299805
| 148
| 7.359375
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,952
| 0
|
68.323
|
female
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 33,471
| 19,604.7969
| null | 14.666664
|
white
| 21.296875
| 37
| 0.768921
| 0.632935
| 3
| 1
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 17
| 67
| 9.599609
| 122
| 26
| 37.79688
| 227.5
| null | null | 1.099854
| 132
| 7.40918
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 223
| 1
|
71.63599
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 7
|
under $11k
| 0
| 10,530
| 7,928.7734
| null | 10.333328
|
white
| 16.097656
| 40
| 0.875
| 0.791992
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 14
| 63
| 8.699219
| 76
| 30
| 36.29688
| 240
| null | null | 1.199951
| 143
| 7.339844
| null | null | null | 2
| 4
|
no(M2 and SIP pres)
| 4
| 1,951
| 0
|
70.76495
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
|
$11-$25k
| 0
| 8,711
| 6,830.3867
| null | 13
|
white
| 23.296875
| 24
| 0.791992
| 0.665894
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 10
| 83
| 10.699219
| 108
| 32
| 36.09375
| 188.5625
| null | null | 1
| 141
| 7.359375
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 252
| 1
|
89.487
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 3,584
| 2,357.1133
| null | 14
|
white
| 18.5
| 22
| 0.740967
| 0.592896
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 3
| 100
| 14.398438
| 86
| 18
| 37.29688
| 200
| null | null | 0.599976
| 138
| 7.329102
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,950
| 0
|
55.80298
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 12
| null | 0
| 3,057
| 1,528.8027
| null | 7
|
white
| 21.796875
| 24
| 0.884888
| 0.807983
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 2
| 90
| 7.5
| 110
| 25
| 37.59375
| 208
| null | null | 0.5
| 139
| 7.349609
| null | null | null | 4
| 6
|
adl>=4 (>=5 if sur)
| 6
| 221
| 1
|
72.59698
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 17,419
| 10,273.3359
| null | 19.666656
|
white
| 23
| 28
| 0.794922
| 0.727905
| 1
| 0
| 0
|
no
| 1
| 0.99
|
no dnr
| 14
| 63
| 4.299805
| 102
| 28
| 37.5
| 365
| 2.799805
| null | 1.699951
| 139
| 7.399414
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 291
| 1
|
79.62994
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 11,895
| 6,759.8086
| null | 11.5
|
white
| 25.898438
| 32
| 0.685913
| 0.592896
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 1
| 75
| 11.099609
| 101
| 26
| 37.19531
| 141.65625
| null | null | 0.799927
| 147
| 7.139648
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,398
| 1
|
71.54297
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 31,316
| 16,828.9375
| null | 29.5
|
white
| 32.195313
| 55
| 0.412964
| 0.292969
| 5
| 0
| 0
|
yes
| 0.15
| 0.12
|
dnr after sadm
| 5
| 60
| 1.299805
| 136
| 32
| 36
| 371.375
| 1.699951
| 0.099991
| 1.799805
| 145
| 7.469727
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 7
| 1
|
42.78998
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 19,185
| 9,497.8828
| null | 37
| null | 50
| 86
| 0.049995
| 0.015999
| 3
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 4
| 49
| 3.899902
| 128
| 28
| 34.5
| 436
| null | 8.5
| 3.899902
| 138
| 7.209961
| null | null | null | null | null |
<2 mo. follow-up
| 2.518066
| 7
| 1
|
73.91895
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 4,780
| 3,638.6152
| null | 10
|
white
| 18.296875
| 31
| 0.853882
| 0.759888
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 97
| null | 76
| 24
| 37.69531
| 256.625
| null | null | 2.799805
| 139
| 7.439453
| null | null | null | 1
| 5
|
<2 mo. follow-up
| 5
| 46
| 1
|
67.37598
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 21,696
| 18,037.2969
| null | 24
|
white
| 31.097656
| 59
| 0.671997
| 0.575928
| 1
| 1
| 0
|
no
| 0.95
| 1
|
no dnr
| 13
| 75
| 11.5
| 150
| 8
| 38.59375
| 121.65625
| null | 0.899902
| 2
| 134
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,945
| 0
|
77.06995
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 0
| 3,634
| 2,929.1738
| null | 9
|
white
| 16.597656
| 31
| 0.862915
| 0.772949
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 6
| 117
| 9.5
| 74
| 16
| 36.29688
| null | 4.199219
| 0.5
| 2.899902
| 135
| null | null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
72.10095
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 24,014
| 18,220.5156
| null | 17
|
white
| 28.796875
| 35
| 0.700928
| 0.53894
| 1
| 0
| 0
|
no
| 0.25
| 0.1
|
dnr after sadm
| 3
| 70
| 3.299805
| 72
| 20
| 36.29688
| null | 3.199707
| null | 5.299805
| 128
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 56
| 1
|
96.422
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 17,637
| 7,842.3086
| null | 26.5
|
white
| 34.5
| 52
| 0.217987
| 0.120987
| 3
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 8
| 51
| 20.597656
| 80
| 28
| 36.09375
| 250
| 2.799805
| null | 3.099609
| 128
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 4.890625
| 11
| 1
|
70.034
|
female
| 0
| 47
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 69,542
| 49,621.9688
| null | 20.25
|
white
| 17.199219
| 32
| 0.875977
| 0.793945
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 47
| 111
| 13.099609
| 80
| 32
| 35.89844
| null | 4
| null | 1.599854
| 141
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,687
| 1
|
65.51697
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 8,659
| 6,245.7969
| null | 12
|
white
| 5.799805
| 16
| 0.868896
| 0.706909
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 80
| 7.099609
| 86
| 20
| 37.5
| null | 4.199219
| null | 1.299805
| 138
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 197
| 1
|
91.67694
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
under $11k
| 0
| 14,107
| 5,900.5625
| null | 32
|
white
| 37.09375
| 55
| 0.265991
| 0.158997
| 1
| 1
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 4
| 46
| 15.099609
| 50
| 26
| 37.69531
| 185
| 3.199707
| 0.699951
| 3.099609
| 136
| 7.289062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
36.53699
|
male
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 0
| 117,256
| 31,268.7656
| null | 28
|
white
| 20.699219
| 33
| 0.897949
| 0.861938
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 62
| 108
| 8.898438
| 110
| 8
| 39.29688
| 202
| 1.899902
| 1.899902
| 1.199951
| 133
| 7.389648
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,941
| 0
|
81.284
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null |
>$50k
| 0
| 5,025
| 3,666.4121
| null | 8
|
white
| 15.898438
| 31
| 0.85791
| 0.764893
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
dnr before sadm
| 0
| 105
| 7.899414
| 58
| 28
| 36.29688
| 304.75
| 3.699707
| null | 1
| 142
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,939
| 0
|
71.16498
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 17,918
| 11,141.7109
| null | 16.5
|
white
| 17.5
| 30
| 0.849976
| 0.797974
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 13
| 73
| 5.799805
| 68
| 27
| 37.79688
| 266.625
| 2.599609
| null | 1.5
| 138
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,938
| 0
|
62.64499
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 9,016
| 2,677.668
| null | 10
|
white
| 35.09375
| 32
| 0.425964
| 0.120987
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
dnr after sadm
| 1
| 80
| 8.898438
| 70
| 25
| 37
| null | 2.799805
| 29
| 0.699951
| 142
| null | null | null | null | 7
| 7
|
<2 mo. follow-up
| 7
| 13
| 1
|
39.31299
|
female
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 24,390
| 15,204.3672
| null | 24.5
|
white
| 29.097656
| 73
| 0.600952
| 0.493958
| 2
| 0
| 0
|
yes
| null | null |
no dnr
| 12
| 135
| 7.199219
| 150
| 42
| 37.5
| 285.6875
| 2.699707
| 2.599609
| 3.099609
| 144
| 7.299805
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,938
| 0
|
77.24799
|
female
| 1
| 47
|
Lung Cancer
|
Cancer
| 1
| null |
under $11k
| 9
| 41,185
| 32,064.5625
| null | 8
|
white
| 12
| 24
| 0.744995
| 0.482971
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 7
| 93
| 18.199219
| 72
| 26
| 37
| null | 4
| 0.699951
| 1.199951
| 134
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 47
| 1
|
41.02698
|
male
| 1
| 47
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 18
|
>$50k
| 0
| 57,856
| 41,057.1875
| null | 10.75
|
white
| 41.796875
| 58
| 0.459961
| 0.257996
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 38
| 73
| 15
| 110
| 24
| 37
| null | 2.899902
| 50.695313
| 5
| 135
| null | null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 47
| 1
|
77.96594
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 15
|
$11-$25k
| 9
| 14,553
| 10,891.6562
| null | 15.666664
|
white
| 21.296875
| 35
| 0.748901
| 0.603882
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 4
| 95
| 10.298828
| 94
| 28
| 37.79688
| 277.75
| null | null | 2.5
| 142
| 7.429688
| null | null | null | null | 3
|
SIP>=30
| 3
| 1,937
| 0
|
62.63898
|
male
| 0
| 18
|
Lung Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 0
| 26,939
| 20,709.8594
| null | 14.666664
|
black
| 13.199219
| 23
| 0.779907
| 0.539917
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.3
|
dnr after sadm
| 7
| 135
| 9.798828
| 48
| 15
| 36.5
| null | 4
| 0.599976
| 1.099854
| 133
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 91
| 1
|
68.27698
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 5,046
| 3,617.6836
| null | 6
|
white
| 16
| 28
| 0.823975
| 0.618896
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.2
|
no dnr
| 6
| 97
| 20
| 72
| 20
| 37.19531
| null | 3.799805
| 0.399963
| 2.199707
| 136
| null | null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 111
| 1
|
68.64099
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 50,918
| 32,448.8281
| null | 23.333328
|
white
| 22.398438
| 41
| 0.669922
| 0.574951
| 5
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 19
| 74
| 14.599609
| 117
| 41
| 38.29688
| 415
| null | null | 0.899902
| 146
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 470
| 1
|
64.43298
|
male
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 20
| null | 9
| 5,135
| 3,777.4356
| null | 12
|
white
| 24.898438
| 47
| 0.67688
| 0.505981
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.5
|
dnr after sadm
| 2
| 115
| 29.898438
| 80
| 40
| 36
| 210
| 3.199707
| null | 0.899902
| 149
| 7.529297
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
86.65295
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 4,723
| 3,616.1152
| null | 9
|
white
| 18.296875
| 43
| 0.810913
| 0.69397
| 1
| 0
| 1
|
no
| 0.9
| 0.8
|
no dnr
| 7
| 71
| 6.5
| 80
| 42
| 35.79688
| 252.375
| 4
| 1.599854
| 1.699951
| 143
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 103
| 1
|
67.409
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 9,601
| 7,057.1562
| null | 6
|
white
| 18.699219
| 19
| 0.834961
| 0.72998
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 12
| 97
| 10.398438
| 69
| 27
| 36
| null | null | null | 1.299805
| 144
| null | null | null | null | null | null | null | 2.505371
| 1,563
| 1
|
71.79999
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 21
| null | 0
| 31,459
| 15,559.6328
| null | 17
|
white
| 22.699219
| 32
| 0.748901
| 0.669922
| 9
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 14
| 53
| 11.898438
| 49
| 24
| 37.39844
| 280.9375
| null | null | 1
| 138
| 7.479492
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 511
| 1
|
84.85999
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 8,570
| 6,200.0781
| null | 13
|
black
| 15.099609
| 22
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| 0.98
| 0.9
|
no dnr
| 10
| 103
| 14.398438
| 80
| 22
| 37.79688
| null | null | null | 1.399902
| 142
| 7.389648
| null | null | null | 3
| null |
no(M2 and SIP pres)
| 2.511099
| 1,478
| 1
|
76.06
|
male
| 1
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 35,239
| 11,708.6641
| null | 38.333313
|
white
| 30.699219
| 36
| 0.601929
| 0.412964
| 1
| 0
| 0
|
no
| 0.95
| 0.75
|
dnr after sadm
| 14
| 61
| 9.798828
| 118
| 12
| 38.19531
| 111.65625
| 2.899902
| 1.299805
| 1.599854
| 136
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
78.672
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 10,477
| 5,305.0938
| null | 14.5
|
white
| 19.296875
| 37
| 0.826904
| 0.767944
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 109
| 10.298828
| 111
| 32
| 37.89844
| 420
| 2.799805
| 0.799927
| 0.899902
| 143
| 7.399414
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,815
| 1
|
30.55199
|
male
| 0
| 32
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 76,135
| 41,028.2812
| null | 22
|
black
| 21.5
| 29
| 0.896973
| 0.826904
| 1
| 0
| 0
|
no
| 0.55
| 0.45
|
no dnr
| 32
| 63
| 15.199219
| 126
| 20
| 38.19531
| 392
| 2.099609
| 3.799805
| 1
| 140
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 304
| 1
|
50.396
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 5
| null | 0
| 4,530
| 3,147.0176
| null | 6
|
black
| 25.597656
| 45
| 0.870972
| 0.785889
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 5
| 51
| 14.398438
| 92
| 24
| 37
| 185.6875
| null | null | 1.299805
| 134
| 7.289062
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,921
| 0
|
56.00299
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
>$50k
| 0
| 10,614
| 7,028.1914
| null | 16
|
white
| 20.296875
| 15
| 0.660889
| 0.358948
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 8
| 116
| 6
| 74
| 28
| 36.69531
| null | 3.299805
| null | 0.599976
| 139
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 409
| 1
|
76.33698
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 9,457
| 6,602.0273
| null | 11.5
|
white
| 20.296875
| 31
| 0.800903
| 0.679932
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 13
| 87
| 9.599609
| 122
| 36
| 38.5
| 340
| null | null | 0.899902
| 143
| 7.419922
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.076172
| 104
| 1
|
59.21399
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 33,298
| 22,645.9688
| null | 19
|
black
| 28.199219
| 37
| 0.725952
| 0.641968
| 4
| 1
| 0
|
no
| null | null |
no dnr
| 12
| 105
| 13.5
| 100
| 40
| 38.59375
| 130
| null | null | 1.799805
| 138
| 7.479492
| null | null | null | null | 1
| null | 1
| 1,919
| 0
|
66.34595
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
| null | 0
| 4,751
| 3,376.4043
| null | 9
|
white
| 17
| 20
| 0.886963
| 0.81189
| 1
| 0
| 0
|
no
| 0.95
| 0.92
|
dnr after sadm
| 1
| 97
| 10.5
| 100
| 32
| 36.59375
| 303.3125
| null | null | 1.099854
| 139
| 7.349609
| null | null | null | 6
| 3
|
no(M2 and SIP pres)
| 3
| 1,916
| 0
|
61.48099
|
female
| 0
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 4
|
$11-$25k
| 0
| 21,507
| 14,395.5781
| null | 12.75
|
white
| 16.597656
| 41
| 0.900879
| 0.833984
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 25
| 105
| 8.798828
| 98
| 32
| 37.09375
| 255.53125
| null | null | 1
| 140
| 7.459961
| null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 1,916
| 0
|
63.27399
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
$11-$25k
| 0
| 7,418
| 4,707.8086
| null | 10
|
white
| 17.699219
| 27
| 0.825928
| 0.715942
| 1
| 1
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 8
| 63
| 9.199219
| 100
| 25
| 36.59375
| 466.625
| 3.699707
| 1.099854
| 1.299805
| 135
| 7.40918
| null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 1,244
| 1
|
79.64996
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 15
|
under $11k
| 0
| 4,776
| 3,234.5801
| null | 13
|
white
| 14.599609
| 10
| 0.855957
| 0.762939
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 85
| 7.299805
| 86
| 20
| 36.79688
| 588.25
| null | null | 0.899902
| 145
| 7.439453
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,915
| 0
|
62.51599
|
female
| 0
| 72
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 134,421
| 35,840.0625
| null | 27.5
|
black
| 19.199219
| 40
| 0.881958
| 0.803955
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 72
| 143
| 7.199219
| 130
| 32
| 38.19531
| 262.9375
| null | null | 1.199951
| 141
| 7.299805
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 135
| 1
|
57.60999
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 14,797
| 9,158.2656
| null | 15.5
|
white
| 15.199219
| 14
| 0.756958
| 0.501953
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 2
| 81
| 2.799805
| 78
| 22
| 35.69531
| null | null | 0.5
| 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 235
| 1
|
85.50598
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 24,531
| 8,586.1094
| null | 26.666656
|
white
| 27.699219
| 47
| 0.650879
| 0.55188
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 14
| 107
| 10.599609
| 55
| 44
| 38.19531
| 134.6875
| null | null | 1.899902
| 143
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
68.29297
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$11-$25k
| 0
| 4,825
| 3,000.5684
| null | 9
|
white
| 18.898438
| 40
| 0.863892
| 0.774902
| 1
| 1
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 6
| 63
| 8.599609
| 61
| 20
| 36.09375
| 319
| 3.699707
| 0.399963
| 2.199707
| 138
| 7.479492
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
88.28699
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 7,485
| 4,946.9727
| null | 8
|
white
| 19.699219
| 27
| 0.727905
| 0.574951
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 69
| 5.5
| 80
| 14
| 36.09375
| 484
| null | null | 0.699951
| 129
| 7.349609
| null | null | null | 4
| 6
|
SIP>=30
| 6
| 1,910
| 0
|
80.32898
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| 10
| null | 0
| 6,066
| 3,936.1367
| null | 14
|
white
| 20.5
| 45
| 0.727905
| 0.455994
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 123
| 7.099609
| 60
| 42
| 38.19531
| null | 2.799805
| 0.599976
| 4.099609
| 144
| null | null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 77
| 1
|
25.92999
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 0
| 31,526
| 33,885.3438
| null | 10.5
|
white
| 30.398438
| 51
| 0.812988
| 0.750977
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 145
| 15.798828
| 120
| 20
| 36.09375
| 136
| null | null | 12.199219
| 135
| 7.199219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,909
| 0
|
85.15796
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 5,272
| 3,606.2617
| null | 6
|
white
| 24.097656
| 39
| 0.7229
| 0.567993
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 55
| 6.599609
| 62
| 40
| 35.39844
| 428.5625
| null | null | 1.299805
| 138
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.181152
| 41
| 1
|
40.375
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 10
|
under $11k
| 0
| 3,558
| 1,725.0977
| null | 5
|
hispanic
| 15.398438
| 10
| 0.957886
| 0.928955
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 83
| 9.898438
| 80
| 20
| 36.69531
| 130
| 4.199219
| 0.399963
| 1
| 143
| 6.969727
| null | null | null | 0
| 1
|
SIP>=30
| 1
| 1,909
| 0
|
65.53595
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 38,225
| 26,093.1875
| null | 12.25
|
white
| 21.398438
| 24
| 0.827881
| 0.769897
| 2
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 50
| 53
| 12.398438
| 77
| 24
| 39.29688
| 185.6875
| 2.5
| 0.299988
| 1
| 143
| 7.419922
| null | null | null | 4
| 3
|
SIP>=30
| 3
| 991
| 1
|
59.35098
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 14,557
| 9,539.7266
| null | 10
|
white
| 25.097656
| 10
| 0.532959
| 0.210999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 13
| 100
| 6.099609
| 108
| 24
| 36.79688
| null | 2.899902
| 0.299988
| 0.699951
| 145
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.055176
| 57
| 1
|
69.95996
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 9
| 33,506
| 29,262.4844
| null | 18.666656
|
white
| 24
| 39
| 0.710938
| 0.622925
| 7
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 23
| 113
| 8.298828
| 63
| 26
| 38.09375
| 175.5
| 2.5
| 0.699951
| 2.599609
| 153
| 7.439453
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,907
| 0
|
83.35394
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
| null | 0
| 6,006
| 4,201.6367
| null | 8.5
|
white
| 17.597656
| 23
| 0.790894
| 0.66394
| 1
| 0
| 0
|
yes
| 0.9
| 0.5
|
no dnr
| 8
| 80
| 11.599609
| 68
| 24
| 36.29688
| null | 3.599609
| 0.5
| 1.5
| 134
| null | null | null | null | 0
| 3
|
no(M2 and SIP pres)
| 3
| 100
| 1
|
62.17697
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 5,648
| 3,686.043
| null | 13
|
black
| 30.398438
| 50
| 0.721924
| 0.566895
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 5
| 63
| 10.398438
| 104
| 28
| 36.79688
| null | 2.099609
| 0.299988
| 2.399902
| 146
| null | null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 1,907
| 0
|
64.63196
|
female
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 14,478
| 8,823.1172
| null | 19.333328
|
white
| 41.195313
| 56
| 0.262939
| 0.096985
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.45
|
dnr after sadm
| 6
| 43
| 6.599609
| 120
| 38
| 34.79688
| 418.5
| 3.599609
| null | 1.299805
| 126
| 7.489258
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 33
| 1
|
77.98798
|
female
| 1
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 12
|
under $11k
| 0
| 28,654
| 8,108.0273
| null | 33
|
white
| 27.796875
| 24
| 0.649902
| 0.471985
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 7
| 50
| 9.599609
| 112
| 8
| 38.39844
| 332.5
| 3.199707
| null | 0.5
| 136
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
25.782
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$25-$50k
| 0
| 9,020
| 3,857.5996
| null | 15
|
other
| 14.599609
| 11
| 0.953979
| 0.93689
| 1
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 7
| 73
| 5.5
| 76
| 24
| 39.09375
| null | 2.799805
| 0.199982
| 1.299805
| 140
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,906
| 0
|
92.95599
|
female
| 1
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 16,444
| 5,627.5742
| null | 18.5
|
white
| 17.398438
| 31
| 0.73291
| 0.581909
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 10
| 68
| 8.599609
| 68
| 24
| 36.79688
| 422.1875
| null | null | 1.799805
| 145
| 7.379883
| null | null | null | 2
| 2
|
<2 mo. follow-up
| 2
| 11
| 1
|
81.56897
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 6,537
| 4,397.2109
| null | 10.5
|
white
| 18.199219
| 33
| 0.829956
| 0.7229
| 1
| 0
| 0
|
no
| 0.99
| 0.98
|
no dnr
| 8
| 69
| 10.699219
| 78
| 22
| 36.09375
| 252
| null | 0.899902
| 1.699951
| 140
| 7.519531
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 396
| 1
|
65.06195
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,867
| 2,508.041
| null | 6
|
white
| 24.296875
| 23
| 0.536987
| 0.213989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 107
| 9.798828
| 98
| 28
| 36.59375
| null | 3.299805
| 0.599976
| 1.199951
| 142
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.242676
| 120
| 1
|
72.047
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 7,914
| 5,386.832
| null | 8.5
|
black
| 13.398438
| 22
| 0.849976
| 0.668945
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
no dnr
| 10
| 73
| 2.399902
| 76
| 20
| 37
| null | null | 0.899902
| 0.899902
| 138
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 389
| 1
|
77.97894
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
| null | 0
| 8,999
| 5,357.5039
| null | 16
|
white
| 30.199219
| 45
| 0.477966
| 0.359985
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 7
| 105
| 17.597656
| 130
| 26
| 36
| 332
| 3.299805
| null | 6.299805
| 137
| 7.429688
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 777
| 1
|
70.44995
|
male
| 1
| 17
|
Coma
|
Coma
| 2
| 20
| null | 61
| 25,671
| 19,454.9688
| null | 15.333328
|
white
| 20.296875
| 23
| 0.431946
| 0.357971
| 2
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 2
| 81
| 10.798828
| 104
| 38
| 39
| 345
| null | null | 1.399902
| 139
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
67.95099
|
female
| 1
| 38
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 33,734
| 22,634.6719
| null | 8.75
|
white
| 15
| 26
| 0.836914
| 0.642944
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 5
| 73
| 10.199219
| 78
| 16
| 36.5
| null | 3.599609
| 0.399963
| 1.599854
| 137
| null | null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 38
| 1
|
75.33197
|
female
| 1
| 60
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 180,272
| 73,283.0625
| null | 41
|
white
| 43.195313
| 76
| 0.28894
| 0.178986
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 45
| 44
| 43.09375
| 105
| 14
| 36.09375
| 265
| 1.5
| 4.599609
| 7.599609
| 128
| 7.329102
| null | null | null | null | 1
| null | 1
| 60
| 1
|
76.646
|
female
| 0
| 20
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 26
| 12,745
| 9,543.7656
| null | 6
|
white
| 18.296875
| 22
| 0.759888
| 0.619995
| 1
| 0
| 1
|
no
| 0.8
| 0.5
|
dnr after sadm
| 1
| 84
| 5.299805
| 76
| 30
| 36.59375
| 238.09375
| null | 0.5
| 0.399963
| 144
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 38
| 1
|
81.28699
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 26
| 12,674
| 6,361.8516
| null | 17.5
|
white
| 22.097656
| 33
| 0.69397
| 0.602905
| 1
| 0
| 1
|
no
| 0.9
| 0.75
|
no dnr
| 12
| 74
| 10.898438
| 60
| 22
| 36.59375
| 408
| 3.299805
| 0.599976
| 2.5
| 137
| 7.459961
| null | null | null | null | null | null | 5.480469
| 137
| 1
|
93.91394
|
female
| 1
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 13,570
| 11,662.1562
| null | 20.5
|
white
| 32.695313
| 55
| 0.330994
| 0.144989
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 42
| 13.199219
| 127
| 26
| 38.29688
| 234
| null | null | 1.399902
| 140
| 7.269531
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 7
| 1
|
80.72296
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 7,633
| 4,950.8477
| null | 15
|
white
| 24.898438
| 56
| 0.654907
| 0.477966
| 1
| 0
| 1
|
no
| 0.8
| 0.7
|
dnr after sadm
| 1
| 112
| 7
| 160
| 28
| 38.19531
| 161.65625
| 4.099609
| null | 2.599609
| 141
| 7.089844
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 108
| 1
|
60.35599
|
male
| 1
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 13,863
| 8,505.2422
| null | 16
|
white
| 59
| 82
| 0.003
| 0
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 3
| 49
| 8.199219
| 130
| 36
| 35.09375
| null | 2.399902
| 20.199219
| 2.799805
| 137
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.29541
| 9
| 1
|
60.34497
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 0
| 86,807
| 67,231.1875
| null | 36
|
white
| 28.199219
| 37
| 0.700928
| 0.610962
| 8
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 18
| 51
| 11.599609
| 102
| 8
| 38.79688
| 168
| null | null | 1.299805
| 147
| 7.259766
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 18
| 1
|
93.77399
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 15,581
| 6,194.3398
| null | 23.5
|
white
| 31.5
| 44
| 0.501953
| 0.384949
| 1
| 0
| 1
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 50
| 3.899902
| 60
| 25
| 36.69531
| 155
| 3
| 0.299988
| 0.899902
| 145
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 5.107422
| 13
| 1
|
70.82794
|
female
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 14,896
| 7,133.4609
| null | 22
|
white
| 30.398438
| 41
| 0.451965
| 0.332947
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.04
|
dnr after sadm
| 2
| 56
| 14.298828
| 102
| 40
| 38.09375
| 114
| 2.799805
| 0.599976
| 0.599976
| 138
| 7.429688
| null | null | null | null | null | null | 2.492676
| 321
| 1
|
69.76898
|
female
| 1
| 9
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 9,542
| 6,106.1094
| null | 15.5
|
white
| 30.796875
| 41
| 0.33197
| 0.064987
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 2
| 70
| 67.296875
| 116
| 38
| 36.79688
| 338.0625
| 2.899902
| 0.399963
| 0.899902
| 143
| 7.459961
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
46.349
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 100,904
| 64,948.5938
| null | 50
|
white
| 40.09375
| 73
| 0.455994
| 0.336975
| 23
| 0
| 0
|
no
| null | null |
dnr after sadm
| 8
| 57
| 23.796875
| 102
| 12
| 37
| 268.3125
| 2.399902
| 39.296875
| 3.899902
| 138
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.762207
| 8
| 1
|
61.14697
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 23,298
| 13,658.8594
| null | 21
|
white
| 22.699219
| 42
| 0.784912
| 0.714966
| 4
| 1
| 0
|
no
| null | null |
no dnr
| 12
| 120
| 11
| 62
| 30
| 38
| 234.6875
| 3
| null | 6.199219
| 140
| 7.319336
| null | null | null | null | null | null | 2.272949
| 161
| 1
|
51.13998
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
under $11k
| 0
| 7,438
| 2,830.9902
| null | 15
|
white
| 15.398438
| 21
| 0.921997
| 0.892944
| 1
| 0
| 0
|
no
| 0.98
| 0.97
|
no dnr
| 6
| 63
| 7.099609
| 75
| 28
| 36.39844
| 256
| null | 0.5
| 0.899902
| 139
| 7.459961
| null | null | null | 2
| 0
|
adl>=4 (>=5 if sur)
| 0
| 1,890
| 0
|
59.69598
|
male
| 0
| 30
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 40,846
| 25,642.7969
| null | 10.75
|
white
| 13.699219
| 22
| 0.863892
| 0.696899
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 30
| 56
| 8
| 80
| 15
| 36.69531
| null | 3.699707
| 0.399963
| 1.099854
| 145
| null | null | null | null | null | null | null | 2.358887
| 122
| 1
|
73.31995
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 28,079
| 14,801.8203
| null | 12.333328
|
white
| 23.597656
| 33
| 0.784912
| 0.714966
| 1
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 25
| 99
| 10.099609
| 102
| 42
| 38.09375
| 144.875
| 2.5
| 0.5
| 0.799927
| 142
| 7.419922
| null | null | null | null | null | null | 2.424805
| 1,887
| 0
|
35.76199
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 14,027
| 6,408.0898
| null | 21.5
|
white
| 23.199219
| 25
| 0.891968
| 0.853882
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 12
| 53
| 14.5
| 106
| 22
| 38
| 212.21875
| 2.299805
| 1.5
| 1.099854
| 138
| 7.469727
| null | null | null | 2
| null |
no(M2 and SIP pres)
| 1.839
| 1,886
| 0
|
77.35797
|
female
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 28,820
| 13,814.8125
| null | 21.666656
|
white
| 42.695313
| 57
| 0.243988
| 0.085999
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 37
| 10.5
| 92
| 40
| 37.59375
| 170
| 2.5
| 0.399963
| 1.099854
| 153
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.270996
| 896
| 1
|
83.57794
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
| null | 37
| 65,318
| 51,210.2188
| null | 47
|
white
| 37.898438
| 72
| 0.058998
| 0.019997
| 15
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 11
| 67
| 19.199219
| 130
| 34
| 38.79688
| 74
| 1.799805
| null | 2.799805
| 133
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
82.80096
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 35,464
| 29,197.8125
| null | 19.666656
|
white
| 23.097656
| 32
| 0.755981
| 0.677979
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 20
| 64
| 13.5
| 54
| 24
| 37.39844
| 190
| null | null | 1.699951
| 134
| 7.439453
| null | null | null | 0
| null | null | 0.4948
| 368
| 1
|
58.82498
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 5,670
| 3,605.0137
| null | 15
|
black
| 10.5
| 13
| 0.824951
| 0.620972
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 5
| 103
| 3.399902
| 64
| 20
| 36.59375
| null | 3.799805
| 0.199982
| 1
| 141
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,625
| 1
|
77.56097
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,333
| 3,607.3574
| null | 13
|
hispanic
| 16.597656
| 22
| 0.827881
| 0.718994
| 1
| 0
| 0
|
yes
| 0.95
| 0.95
|
no dnr
| 7
| 107
| 7.799805
| 78
| 24
| 35.79688
| null | null | 0.899902
| 1.399902
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,883
| 0
|
53.70297
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 91,986
| 72,924.0625
| null | 34.25
|
white
| 25.796875
| 36
| 0.796997
| 0.72998
| 3
| 1
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 47
| 65
| 18.296875
| 150
| 10
| 38.29688
| 164
| null | null | 0.599976
| 137
| 7.509766
| null | null | null | null | 1
|
SIP>=30
| 1
| 1,794
| 1
|
78.43695
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 17,635
| 6,980.957
| null | 40
|
white
| 39.195313
| 61
| 0.18399
| 0.095993
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 5
| 49
| 1.399902
| 140
| 24
| 39
| 138
| 1.799805
| 1.599854
| 1.099854
| 144
| 7.319336
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
52.68997
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 11,201
| 6,830.2617
| null | 13.5
|
white
| 23.597656
| 32
| 0.880981
| 0.800903
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 10
| 110
| 13.099609
| 120
| 30
| 36.69531
| 192.84375
| null | 0.699951
| 0.899902
| 137
| 7.389648
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 858
| 1
|
44.30399
|
female
| 1
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 9
| 56,112
| 21,248.1875
| null | 30
|
black
| 25.699219
| 38
| 0.767944
| 0.630981
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 20
| 59
| 12.398438
| 139
| 21
| 39.09375
| 432
| 3.299805
| 5.899414
| 0.899902
| 138
| 7.40918
| null | null | null | 7
| 0
|
<2 mo. follow-up
| 0
| 21
| 1
|
82.09399
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
under $11k
| 0
| 15,079
| 5,353.8984
| null | 54
|
white
| 75.890625
| 96
| 0
| 0
| 2
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 0
| 11.5
| 0
| 0
| 35.59375
| 306
| null | 0.699951
| 2.299805
| 135
| 7.269531
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
44.48199
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 13,559
| 6,085.4531
| null | 20
|
white
| 27.699219
| 26
| 0.816895
| 0.702881
| 3
| 0
| 0
|
no
| 0.75
| 0.4
|
no dnr
| 7
| 51
| 10.5
| 122
| 20
| 37
| 352.375
| null | null | 0.599976
| 135
| 7.469727
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,880
| 0
|
75.086
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 38,936
| 31,189.4219
| null | 35.333313
|
white
| 31.398438
| 34
| 0.416992
| 0.296997
| 3
| 0
| 0
|
metastatic
| 0.5
| 0.05
|
dnr after sadm
| 14
| 55
| 13.199219
| 118
| 12
| 38.5
| 101.42188
| null | null | 0.699951
| 141
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.